Promising New Nanomedical Cancer Therapy Also Highlights Tech Transfer, Inventor Says
If a new approach to cancer therapy, still experimental and in a phase I clinical trial, turns out as well as hoped, the credit will go as much to technology transfer as to scientific acumen.